

Please try another search
Investing.com - Collplant ADR (NASDAQ: CLGN) reported first quarter EPS of $-0.29, in line with the analyst estimate of $-0.29. Revenue for the quarter came in at $433K versus the consensus estimate...
Stratasys Ltd. (Nasdaq: NASDAQ:SSYS) and CollPlant Biotechnologies (Nasdaq: CLGN) today announced a joint development and commercialization agreement to collaborate on the development of a solution...
Investing.com - Collplant ADR (NASDAQ: CLGN) reported first quarter EPS of $-0.38, $0.17 worse than the analyst estimate of $-0.21. Revenue for the quarter came in at $409K versus the consensus...
Investing.com - Collplant ADR (NASDAQ: CLGN) reported fourth quarter EPS of $-0.40, $0.09 worse than the analyst estimate of $-0.31. Revenue for the quarter came in at $109K versus the consensus...
Investing.com - Collplant ADR reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Collplant ADR announced earnings per share of...
Investing.com - Collplant ADR reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Collplant ADR announced earnings per share of...
Investing.com - Collplant ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Collplant ADR announced earnings per share of $0.16 on...
Investing.com - Collplant ADR reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Collplant ADR announced earnings per share of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review